摘要

关键词：
• STAT1 基因敲除小鼠
• , 克里米亚-刚果出血热病毒(CCHFV)
• , 凝血障碍
• , 动物模型

Abstract

References

1. Bente, D.A., Alimonti, J.B., Shieh, W.J., Camus, G., Stroher, U., Zaki, S.,Jones, S.M., 2010. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol, 84, 11089-11100.
   

2. Bozkurt, I.,Esen, S., 2021. Association Between Severity Grading Score And Acute Phase Reactants In Patients With Crimean Congo Hemorrhagic Fever. Pathog Glob Health, 115, 496-498.
   

3. Frank, M.G., Weaver, G.,Raabe, V., 2024. Crimean-Congo Hemorrhagic Fever Virus for Clinicians-Epidemiology, Clinical Manifestations, and Prevention. Emerg Infect Dis, 30, 854-863.
   

4. Guo, R., Shen, S., Zhang, Y., Shi, J., Su, Z., Liu, D., Liu, J., Yang, J., Wang, Q., Hu, Z., Zhang, Y.,Deng, F., 2017. A new strain of Crimean-Congo hemorrhagic fever virus isolated from Xinjiang, China. Virol Sin, 32, 80-88.
   

5. Hasanoglu, I., Guner, R., Carhan, A., Kocak Tufan, Z., Yagci-Caglayik, D., Guven, T., Yilmaz, G.R.,Tasyaran, M.A., 2016. Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: Viral load. J Clin Virol, 75, 42-46.
   

6. Hawman, D.W.,Feldmann, H., 2023. Crimean-Congo haemorrhagic fever virus. Nat Rev Microbiol, 21, 463-477.
   

7. Kaya, S., Elaldi, N., Kubar, A., Gursoy, N., Yilmaz, M., Karakus, G., Gunes, T., Polat, Z., Gozel, M.G., Engin, A., Dokmetas, I., Bakir, M., Yilmaz, N.,Sencan, M., 2014. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect Dis, 14, 416.
   

8. Ozturk, B., Tutuncu, E., Kuscu, F., Gurbuz, Y., Sencan, I.,Tuzun, H., 2012. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int J Infect Dis, 16, e89-93.
   

9. Rodriguez, S.E., Hawman, D.W., Sorvillo, T.E., O'neal, T.J., Bird, B.H., Rodriguez, L.L., Bergeron, E., Nichol, S.T., Montgomery, J.M., Spiropoulou, C.F.,Spengler, J.R., 2022. Immunobiology of Crimean-Congo hemorrhagic fever. Antiviral Res, 199, 105244.
   

10. Semper, A.E., Olver, J., Warner, J., Cehovin, A., Fay, P.C., Hart, P.J., Golding, J.P., Benassi, V., Preziosi, M.P., Al-Asadi, K.H.R., Blumberg, L.H., De La Fuente, J., Elaldi, N., Fletcher, T., Formenty, P.B.H., Gouya, M.M., Gunther, S., Hewson, R., Jamil, B., Kobinger, G., Korukluoglu, G., Lempereur, L., Palacios, G., Papa, A., Pshenichnaya, N., Schmaljohn, C., Sow, S.O., Sprong, H., Vatansever, Z.,Brooks, T.J.G., 2024. Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30. Lancet Infect Dis, 24, 00656-x.
    

11. Song, J.C., Zhang, W., Zhang, L., Yang, J., Zhang, J.H., Zhou, J., Wang, Q.S.,Li, W.Q., 2022. Consensus of Chinese experts on standardized evaluation of coagulation dysfunction in severe patients. Med J Chin PLA, 47, 107-117.
    

12. Thrombosis and Hemostasis Group, Hematology Society of Chinese Medical Association, 2017. Consensus of Chinese experts on diagnosis of disseminated intravascular coagulation (version 2017). Chin J Hematol, 38, 361-363.
    

13. Zivcec, M., Safronetz, D., Scott, D., Robertson, S., Ebihara, H.,Feldmann, H., 2013. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J Infect Dis, 207, 1909-1921.
    

Proportional views

Electronic Supplementary Material

10.1016j.virs.2025.04.008-ESM.docx